Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-19

FDA Approved: TECVAYLI — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TECVAYLI (teclistamab-cqyv) from Janssen Biotech, Inc., resulting in an updated label that expands the approved indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TECVAYLI (TECLISTAMAB-CQYV)

Snippet

SUPPL AP for TECVAYLI (TECLISTAMAB-CQYV)